Trial intelligence / Profile preview

Lidocaine 5% Patch for Prevention of Pain After Robotic Valve Surgery

NCT03120351Completed

Sponsor
Cleveland Clinic
Start
Sep 2009
Primary completion
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in post-thoracotomy pain syndrome (PTPS) (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Pain Disability Index at 6 months. Started Sep 2009; status: completed.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

post-thoracotomy pain syndrome (PTPS)

Beyond the preview

Go deeper on NCT03120351.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03120351.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call